Regulation of cellular and system function by activin

Biochemical Pharmacology

Volumn 55, Issue 7, 1998, Pages 953-963

  Woodruff, Teresa K ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Activin; Development; Inhibin; Ovary; Reproduction; TGF

Indexed keywords

ACTIVIN; ACTIVIN RECEPTOR; CELL SURFACE RECEPTOR; FOLLISTATIN; INHIBIN A; PROTEIN SERINE THREONINE KINASE; RECEPTOR SUBUNIT; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

CELL DIFFERENTIATION; FOLLITROPIN RELEASE; HOMEOSTASIS; HORMONE SYNTHESIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; REPRODUCTION; REVIEW; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY;

EID: 0032055268     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00477-2     Document Type: Article

References (155)

1. Vale W., Rivier C., Hsueh A., Campen C., Meunier H., Bicsak T. Chemical and biological characterization of the inhibin family of protein hormones. Recent Prog Horm Res. 44:1988;1-34.
2. Mathews L. Activin receptors and cellular signaling by the receptor serine kinase family. Endocr Rev. 15:1994;310-325.
3. Massagué J., Cheifetz S., Laiho M., Ralph D., Weis F., Zentella A. Transforming growth factor-beta. Cancer Surv. 12:1992;81-103.
4. Hogan B.L. Bone morphogenetic proteins Multifunctional regulators of vertebrate development . Genes Dev. 10:1996;1580-1594.
5. Mayo K.E. Inhibin and activin Molecular aspects of regulation and function . Trends Endocrinol Metab. 5:1994;407-415.
6. Teixeira J., Donahoe P.K. Molecular biology of MIS and its receptors. J Androl. 17:1996;336-341.
7. Kingsley D.M. The TGF-β superfamily: New members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 8:1994;133-146.
8. Massagué J., Weis-Garcia F. Serine/threonine kinase receptors Mediators of transforming growth factor beta family signals . Cancer Surv. 27:1996;41-64.
9. C (Inhbc) gene. Genomics. 32:1996;358-366.
10. Oda S., Nishimatsu S., Murakami K., Ueno N. Molecular cloning and functional analysis of a new activin β subunit A dorsal mesoderm-inducing activity in Xenopus . Biochem Biophys Res Commun. 210:1995;581-588.
11. E subunit gene. Biochem Biophys Res Commun. 228:1996;669-674.
12. Roberts A.B., Sporn M.B. The transforming growth factor betas. Sporn M.B., Roberts A.B. Peptide Growth Factors and Their Receptors. 1990;419-472 Springer, Heidelberg.
13. Pircher R., Jullien P., Lawrence D.A. β-Transforming growth factor is stored in human blood platelets as a latent high molecular weight complex. Biochem Biophys Res Commun. 136:1986;30-37.
14. DePaolo L., Bicsak T., Erickson G., Shimasaki S., Ling N. Follistatin and activin A potential intrinsic regulatory system within diverse tissues . Proc Soc Exp Biol Med. 198:1991;500-512.
15. Besecke L.M., Guendner M.J., Schneyer A.L., Bauer-Dantoin A.C., Jameson J.L., Weiss J. Gonadotropin-releasing hormone regulates follicle-stimulating hormone-beta gene expression through an activin/follistatin autocrine or paracrine loop. Endocrinology. 137:1996;3667-3673.
16. Krummen L., Woodruff T., DeGuzman G., Cox E., Baly D., Mann E., Garg S., Wong W., Cossum P., Mather J. Identification and characterization of binding proteins for inhibin and activin in human serum and follicular fluids. Endocrinology. 132:1993;431-443.
17. 2-Macroglobulin is a binding protein of inhibin and activin. Endocrinology. 132:1993;2038-2050.
18. Daopin S., Li M., Davies D.R. Crystal structure of TGF-β2 refined at 1.8 Å resolution. Proteins. 17:1993;176-192.
19. Griffith D.L., Keck P.C., Sampath T.K., Rueger D.C., Carlson W.D. Three-dimensional structure of recombinant human osteogenic protein 1 Structural paradigm for the transforming growth factor β superfamily . Proc Natl Acad Sci USA. 93:1996;878-883.
20. Sun P.D., Davies D.R. The cystine-knot growth-factor superfamily. Annu Rev Biophys Biomol Struct. 24:1995;269-291.
21. Qian S.W., Burmester J.K., Sun P.D., Huang A., Ohlsen D.J., Suardet L., Flanders K.C., Davies D., Roberts A.B., Sporn M.B. Characterization of mutated transforming growth factor-β which possess unique biological properties. Biochemistry. 33:1994;12298-12304.
22. Qian S.W., Burmester J.K., Tsang ML-S, Weatherbee J.A., Hinck A.P., Ohlsen D.J., Sporn M.B., Roberts A.B. Binding affinity of transforming growth factor-β for its type II receptor is determined by the C-terminal region of the molecule. J Biol Chem. 271:1996;30656-30662.
23. Lin H., Wang X., Ng-Eaton E., Weinberg R., Lodish H. Expression cloning of the TGFβ type II receptor, a functional transmembrane serine/threonine kinase. Cell. 68:1992;775-785.
24. Franzén P., ten Dijke P., Ichijo H., Yamashita H., Schulz P., Heldin C-H, Miyazono K. Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor. Cell. 75:1993;681-692.
25. Attisano L., Wrana J., Cheifetz S., Massagué J. Novel activin receptors Distinct genes and alternative mRNA splicing generate a repertoire of serine threonine kinase receptors . Cell. 86:1992;97-108.
26. Estevez M., Attisano L., Wrana J.L., Albert P.S., Massagué J., Riddle D.L. The daf-4 gene encodes a bone morphogenetic protein receptor controlling C. elegans dauer larva development. Nature. 365:1993;644-649.
27. He W.W., Gustafson M.L., Hirobe S., Donahoe P.K. Developmental expression of four novel serine/threonine kinase receptors homologous to the activin/transforming growth factor-β type II receptor family. Dev Dyn. 196:1993;133-142.
28. Attisano L., Carcamo J., Bentura F., Weis F., Massagué J., Wrana J. Identification of human activin and TGF-β type I receptors that form heteromeric kinase complexes with type II receptors. Cell. 75:1993;671-680.
29. Ebner R., Chen R-H, Lawler S., Zioncheck T., Derynck R. Determination of type I receptor specificity by the type II receptors for TGF-β or activin. Science. 262:1993;900-902.
30. Wrana J.L., Tran H., Attisano L., Arora K., Childs S.R., Massagué J., O'Connor M.B. Two distinct transmembrane serine/threonine kinases from Drosophila melanogaster form an activin receptor complex. Mol Cell Biol. 14:1994;944-950.
31. Mathews L.S., Vale W.W. Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Cell. 65:1991;973-982.
32. Mathews L.S., Vale W.W. Characterization of type II activin receptors Binding, processing, and phosphorylation . J Biol Chem. 268:1993;19013-19018.
33. Willis S.A., Zimmerman C.M., Li L.I., Mathews L.S. Formation and activation by phosphorylation of activin receptor complexes. Mol Endocrinol. 10:1996;367-379.
34. Tsuchida K., Vaughan J.M., Wiater E., Gaddy-Kurten D., Vale W.W. Inactivation of activin-dependent transcription by kinase-deficient activin receptors. Endocrinology. 136:1995;5493-5503.
35. De Winter J.P., De Vries C.J., Van Achterberg T.A., Ameerun R.F., Feijen A., Sugino H., De Waele P., Huylebroeck D., Verschueren K., Van Den Eijden-Van Raaij A.J. Truncated activin type II receptors inhibit bioactivity by the formation of heteromeric complexes with activin type I receptors. Exp Cell Res. 224:1996;323-334.
36. Attisano L., Wrana J.L., Montalvo E., Massagué J. Activation of signalling by the activin receptor complex. Mol Cell Biol. 16:1996;1066-1073.
37. Wieser R., Wrana J.L., Massagué J. GS domain mutations that constitutively activate TβR-I, the downstream signaling component in the TGF-β receptor complex. EMBO J. 14:1995;2199-2208.
38. Ventura F., Doody J., Liu F., Wrana J.L., Massagué J. Reconstitution and transphosphorylation of TGF-β receptor complexes. EMBO J. 13:1994;5581-5589.
39. Wrana J.L., Attisano L., Wieser R., Ventura F., Massagué J. Mechanism of activation of the TGF-β receptor. Nature. 370:1994;341-347.
40. Chen R-H, Moses H.L., Maruoka E.M., Derynck R., Kawabata M. Phosphorylation-dependent interaction of the cytoplasmic domains of the type I and type II transforming growth factor-β receptors. J Biol Chem. 270:1995;12235-12241.
41. Chen F., Weinberg R.A. Biochemical evidence for the autophosphorylation and transphosphorylation of transforming growth factor β receptor kinases. Proc Natl Acad Sci USA. 92:1995;1565-1569.
42. Franzén P., Heldin C-H, Miyazono K. The GS domain of the transforming growth factor-β type I receptor is important in signal transduction. Biochem Biophys Res Commun. 207:1995;682-689.
43. ten Dijke P., Yamashita H., Ichijo H., Franzén P., Laiho M., Miyazono K., Heldin C-H. Characterization of type I receptors for transforming growth factor-β and activin. Science. 264:1994;101-104.
44. ten Dijke P., Ichijo H., Franzén P., Schulz P., Saras J., Toyoshima H., Heldin C-H, Miyazono K. Activin receptor-like kinases A novel subclass of cell-surface receptors with predicted serine/threonine kinase activity . Oncogene. 8:1993;2879-2887.
45. Verschueren K., Dewulf N., Goumans M.J., Lonnoy O., Feijen A., Grimsby S., Spiegle K., ten Dijke P., Moren A., Vanscheeuwijck P. Expression of type I and type IB receptors for activin in midgestation mouse embryos suggests distinct functions in organogenesis. Mech Dev. 52:1995;109-123.
46. Roberts V.J., Barth S.L. Expression of messenger ribonucleic acids encoding the inhibin/activin system during mid- and late-gestation rat embryogenesis. Endocrinology. 134:1994;914-923.
47. Roberts V.J., Bentley C.A., Guo Q., Matzuk M.M., Woodruff T.K. Tissue-specific binding of radiolabeled activin A by activin receptors and follistatin in postimplantation rat and mouse embryos. Endocrinology. 137:1996;4201-4209.
48. Roberts V.J., Barth S.L., Meunier H., Vale W. Hybridization histochemical and immunohistochemical localization of inhibin/activin subunits and messenger ribonucleic acids in the rat brain. J Comp Neurol. 364:1996;473-493.
49. Cameron V.A., Nishimura E., Mathews L.S., Lewis K.A., Sawchenko P.E., Vale W.W. Hybridization histochemical localization of activin receptor subtypes in rat brain, pituitary, ovary, and testis. Endocrinology. 134:1994;799-808.
50. Matzuk M.M., Kumar T.R., Shou W., Coerver K.A., Lau A.L., Behringer R.R., Finegold M.J. Transgenic models to study the roles of inhibins and activins in reproduction, oncogenesis, and development. Recent Prog Horm Res. 51:1996;123-154.
51. Kumar T.R., Donehower L.A., Bradley A., Matzuk M.M. Transgenic mouse models for tumour-suppressor genes. J Intern Med. 238:1995;233-238.
52. Matzuk M.M., Bradley A. Identification and analysis of tumor suppressor genes using transgenic mouse models. Semin Cancer Biol. 5:1994;37-45.
53. Matzuk M.M., Kumar T.R., Vassalli A., Bickenbach J.R., Roop D.R., Jaenisch R. Functional analysis of activins during mammalian development. Nature. 374:1995;354-356.
54. Vassalli A., Matzuk M.M., Gardner H.A.R., Lee K-F, Jaenisch R. Activin/inhibin βB subunit gene disruption leads to defects in eyelid development and female reproduction. Genes Dev. 8:1994;414-427.
55. Matzuk M.M., Kumar T.R., Bradley A. Different phenotypes for mice deficient in either activins or activin receptor type II. Nature. 374:1995;356-360.
56. Yamashita H., ten Dijke P., Huylebroeck D., Sampath T.K., Andries M., Smith J.C., Heldin C.H., Miyazono K. Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects. J Cell Biol. 130:1995;217-226.
57. Matzuk M.M., Lu N., Vogel H., Sellheyer K., Roop D.R., Bradley A. Multiple defects and perinatal death in mice deficient in follistatin. Nature. 374:1995;360-363.
58. Mishina Y., Rey R., Finegold M.J., Matzuk M.M., Josso N., Cate R.L., Behringer R.R. Genetic analysis of the Müllerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation. Genes Dev. 10:1996;2577-2587.
59. Yamashita H., ten Dijke P., Franzén P., Miyazono K., Heldin C-H. Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-β J Biol Chem. 269:1994;20172-20178.
60. ten Dijke P., Yamashita H., Sampath T.K., Reddi A.H., Estevez M., Riddle D.L., Ichijo H., Heldin C-H, Miyazono K. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J Biol Chem. 269:1994;16985-16988.
61. Treanor J.J., Goodman L., de Sauvage F., Stone D.M., Poulsen K.T., Beck C.D., Gray C., Armanini M.P., Pollock R.A., Hefti F., Phillips H.S., Goddard A., Moore M.W., Buj-Bello A., Davies A.M., Asai N., Takahashi M., Vandlen R., Henderson C.E., Rosenthal A. Characterization of a multicomponent receptor for GDNF. Nature. 382:1996;80-82.
62. Durbec P., Marcos-Gutierrez C.V., Kilkenny C., Grigoriou M., Wartiowaara K., Suvanto P., Smith D., Ponder B., Costantini F., Saarma M.T., Sariola H., Pachnis V. GDNF signalling through the Ret receptor tyrosine kinase. Nature. 381:1996;789-793.
63. Wang X-F, Lin H.Y., Ng-Eaton E., Downward J., Lodish H.F., Weinberg R.A. Expression cloning and characterization of the TGF-β type III receptor. Cell. 67:1991;797-805.
64. Weiss J., Harris P.E., Halvorson L.M., Crowley W.F. Jr, Jameson J.L. Dynamic regulation of follicle-stimulating hormone-β messenger ribonucleic acid levels by activin and gonadotropin-releasing hormone in perifused rat pituitary cells. Endocrinology. 131:1992;1403-1408.
65. Lebrun J.J., Vale W.W. Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation. Mol Cell Biol. 17:1997;1682-1691.
66. Woodruff T.K., Lyon R.J., Hansen S.E., Rice G.C., Mather J.P. Inhibin and activin locally regulate rat ovarian folliculogenesis. Endocrinology. 127:1990;3196-3205.
67. 125I]inhibin-A to the adult rat ovary. Endocrinology. 133:1993;2998-3006.
68. Krummen L.A., Moore A., Woodruff T.K., Covello R., Taylor R., Working P., Mather J.P. Localization of inhibin and activin binding sites in the testis during development by in situ ligand binding. Biol Reprod. 50:1994;734-744.
69. Chen R-H, Miettinen P.J., Maruoka E.M., Choy L., Derynck R. A WD-domain protein that is associated with and phosphorylated by the type II TGF-β receptor. Nature. 377:1995;548-552.
70. Wang T., Donahoe P.K., Zervos A.S. Specific interaction of type I receptors of the TGF-β family with the immunophilin FKBP-12. Science. 265:1994;674-676.
71. (RAS) farnesyltransferase α subunit in TGF-β and activin signaling. Science. 271:1996;1120-1122.
72. Jayaraman T., Brillantes A., Timerman A., Fleischer S., Erdjument-Bromage H., Tempst P., Marks A. FK506 binding protein associated with the calcium release channel (ryanodine receptor). J Biol Chem. 267:1992;9474-9477.
73. 2+ flux. Cell. 83:1995;463-472.
74. Wang T., Li B-Y, Danielson P.D., Shah P.C., Rockwell S., Lechleider R.J., Martin J., Manganaro T., Donahoe P.K. The immunophilin FKBP12 functions as a common inhibitor of the TGFβ family type I receptors. Cell. 86:1996;435-444.
75. Mogami H., Kanzaki M., Nobusawa R., Ahang Y., Furukawa M., Kojima I. Modulation of adenosine triphosphate-sensitive potassium channel and voltage-dependent calcium channel by activin A in HIT-T15 cells. Endocrinology. 136:1995;2960-2966.
76. Mine T., Kojima I., Ogata E. Pertussis toxin blocks activin A-induced production of inositol phosphates in rat hepatocytes. Biochem Biophys Res Commun. 186:1992;205-210.
77. Kawabata M., Imamura T., Miyazono K., Engel M.E., Moses H.L. Interaction of the transforming growth factor-β type I receptor with farnesyl-protein transferase-α J Biol Chem. 270:1995;29628-29631.
78. Ventura F., Liu F., Doody J., Massagué J. Interaction of transforming growth factor-β receptor I with farnesyl-protein transferase-α in yeast and mammalian cells. J Biol Chem. 271:1996;13931-13934.
79. Hancock J.F., Magee A.I., Childs J.E., Marshall C.J. All ras proteins are polyisoprenylated but only some are palmitoylated. Cell. 57:1989;1167-1177.
80. LaBonne C., Whitman M. Mesoderm induction by activin requires FGF-mediated intracellular signals. Development. 120:1994;463-472.
81. MacNicol A.M., Muslin A.J., Williams L.T. Raf-1 kinase is essential for early Xenopus development and mediates the induction of mesoderm by FGF. Cell. 73:1993;571-583.
82. Hartsough M.T., Frey R.S., Zipfel P.A., Buard A., Cook S.J., McCormick F., Mulder K.M. Altered transforming growth factor β signaling in epithelial cells when Ras activation is blocked. J Biol Chem. 271:1996;22368-22375.
83. Sekelsky J.J., Newfeld S.J., Raftery L.A., Chartoff E.H., Gelbart W.M. Genetic characterization and cloning of Mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster. Genetics. 139:1995;1347-1358.
84. Massagué J. TGFβ signaling Receptors, transducers, and Mad proteins . Cell. 85:1996;947-950.
85. Graff J., Bansal A., Melton D. Xenopus Mad proteins transduce distinct subsets of signals for the TGFβ superfamily. Cell. 85:1996;479-487.
86. Derynck R., Gelbart W.M., Harland R.M., Heldin C-H, Kern S.E., Massagué J., Melton D.A., Mlodzik M., Padgett R.W., Roberts A.B., Smith J., Thomsen G.H., Vogelstein B., Wang X-F. Nomenclature Vertebrate mediators of TGFβ family signals . Cell. 87:1996;173.
87. Hoodless P.A., Haerry T., Abdollah S., Stapleton M., O'Connor M.B., Attisano L., Wrana J.L. MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell. 85:1996;489-500.
88. Liu F., Hata A., Baker J., Doody J., Carcamo J., Harland R., Massagué J. A human Mad protein activin as a BMP-regulated transcriptional activator. Nature. 381:1996;620-623.
89. Lagna G., Hata A., Hemmati-Brivanlou A., Massagué J. Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways. Nature. 383:1996;832-836.
90. Eppert K., Scherer S.W., Ozcelik H., Pirone R., Hoodless P., Kim H., Tsui L-C, Bapat B., Gallinger S., Andrulis I.L., Thomsen G.H., Wrana J.L., Attisano L. MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell. 86:1996;543-552.
91. Macías-Silva M., Abdollah S., Hoodless P.A., Pirone R., Attisano L., Wrana J.L. MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell. 87:1996;1215-1224.
92. Wu R-Y, Zhang Y., Feng X-H, Derynck R. Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/DPC4. Mol Cell Biol. 17:1997;2521-2528.
93. Hahn S.A., Schutte M., Hoque ATMS, Moskaluk C.A., da Costa L.T., Rozenblum E., Weinstein C.L., Fischer A., Yeo C.J., Hruban R.H., Kern S.E. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science. 271:1996;350-353.
94. Schutte M., Hruban R.H., Hedrick L., Cho K.R., Nadasdy G.M., Weinstein C.L., Bova G.S., Isaacs W.B., Cairns P., Nawroz H., Sidransky D., Casero R.A. Jr, Meltzer P.S., Hahn S.A., Kern S.E. DPC4 gene in various tumor types. Cancer Res. 56:1996;2527-2530.
95. Yingling J.M., Das P., Savage C., Zhang M., Padgett R.W., Wang X-F. Mammalian dwarfins are phosphorylated in response to transforming growth factor β and are implicated in control of cell growth. Proc Natl Acad Sci USA. 93:1996;8940-8944.
96. Riggins G.J., Thiagalingam S., Rozenblum E., Weinstein C.L., Kern S.E., Hamilton S.R., Willson J.K.V., Markowitz S.D., Kinzler K.W., Vogelstein B. Mad-related genes in the human. Nat Genet. 13:1996;347-349.
97. Kalkhoven E., Roelen B.A., de Winter J.P., Mummery C.L., van den Eijnden-van Raaij A.J.M., van der Saag P.T., van der Burg B. Resistance to transforming growth factor β and activin due to reduced receptor expression in human breast tumor cell lines. Cell Growth Differ. 6:1995;1151-1161.
98. Grieder N.C., Nellen D., Burke R., Basler K., Affolter M. schnurri is required for Drosophila Dpp signaling and encodes a zinc finger protein similar to the mammalian transcription factor PRDII-BF1. Cell. 81:1995;791-800.
99. Staehling K., Laughon A., Hoffmann F. A Drosophila protein related to the human zinc finger transcription factor PRDII/MBPI/HIV-EP1 is required for dpp signaling. Development. 121:1995;3393-3403.
100. Raftery L.A., Twombly V., Wharton K., Gelbart W.M. Genetic screens to identify elements of the decapentaplegic signaling pathway in Drosophila. Genetics. 139:1995;241-254.
101. Otsuka M., Fujita M., Aoki T., Ishii S., Sugiura Y., Yamamoto T., Inoue J-I. Novel zinc chelators with dual activity in the inhibition of the κB site-binding proteins HIV-EP1 and NF-κB. J Med Chem. 38:1995;3264-3270.
102. Chen X., Rubock M.J., Whitman M. A transcriptional partner for MAD proteins in TGF-β signalling. Nature. 383:1996;691-696.
103. Iozzo R.V., Pillarisetti J., Sharma B., Murdoch A.D., Danielson K.G., Uitto J., Mauviel A. Structural and functional characterization of the human perlecan gene promoter. Transcriptional activation by transforming growth factor-β via a nuclear factor 1-binding element. J Biol Chem. 272:1997;5219-5228.
104. Hashimoto M., Gaddy-Kurten D., Vale W. Protooncogene junB as a target for activin actions. Endocrinology. 133:1993;1934-1940.
105. Woodruff T., Mather J. Inhibin, activin and the female reproductive axis. Annu Rev Physiol. 57:1995;219-244.
106. Schwall R., Mason A., Wilcox J., Bassett S., Zeleznik A. Localization of inhibin/activin subunit mRNAs within the primate ovary. Mol Endocrinol. 4:1990;75-79.
107. Roberts V., Barth S., El-Roeiy A., Yen S. Expression of inhibin/activin subunits and follistatin mRNAs and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle. J Clin Endocrinol Metab. 77:1993;1402-1410.
108. Roberts V., Barth S., El-Roeiy A., Yen S. Expression of inhibin/activin system messenger ribonucleic acids and proteins in ovarian follicles from women with polycystic ovarian syndrome. J Clin Endocrinol Metab. 79:1994;1434-1439.
109. Braw-Tal R. Expression of mRNA for follistatin and inhibin/activin subunits during follicular growth and atresia. J Mol Endocrinol. 13:1994;253-264.
110. Muttukrishna S., Fowler P., Groome N.P., Mitchell G.G., Robertson W.R., Knight P.G. Serum concentrations of dimeric inhibin during the spontaneous human menstrual cycle and after treatment with exogenous gonadotrophin. Hum Reprod. 9:1994;1634-1642.
111. Groome N.P., Illingworth P.J., O'Brien M., Pai R., Rodger F.E., Mather J.P., McNeilly A.S. Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab. 81:1996;1401-1405.
112. Woodruff T.K., Besecke L.M., Groome N., Draper L.B., Schwartz N.B., Weiss J. Inhibin A and inhibin B are inversely correlated to follicle-stimulating hormone, yet are discordant during the follicular phase of the rat estrous cycle, and inhibin A is expressed in a sexually dimorphic manner. Endocrinology. 137:1996;5463-5467.
113. Fraser H.M., Lunn S.F. Does inhibin have an endocrine function during the menstrual cycle? Trends Endocrinol Metab. 4:1993;187-194.
114. McLachlan R.I., Burger H.G., Healy D.L., de Kretser D.M., Robertson D.M. Circulating immunoreactive inhibin in the luteal phase and early gestation of women undergoing ovulation induction. Fertil Steril. 48:1987;1001-1005.
115. Reddi K., Wickings E.J., McNeilly A.S., Baird D.T., Hillier S.G. Circulating bioactive follicle stimulation hormone and immunoreactive inhibin levels during the normal human menstrual cycle. Clin Endocrinol. 33:1990;547-557.
116. Roseff S.J., Bangah M.L., Kettel L.M., Vale W., Rivier J., Gaburger H., Yen S.S.C. Dynamic changes in circulating inhibin levels during the luteal-follicular transition of the human menstrual cycle. J Clin Endocrinol Metab. 69:1989;1033-1039.
117. Lockwood G.M., Muttukrishna S., Groome N.P., Knight P.G., Ledger W.L. Circulating inhibins and activin A during GnRH-analogue down-regulation and ovarian hyperstimulation with recombinant FSH for in-vitro fertilization-embryo transfer. Clin Endocrinol. 45:1996;741-748.
118. Klein N.A., Illingworth P.J., Groome N.P., McNeilly A.S., Battaglia D.E., Soules M.R. Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women A study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles . J Clin Endocrinol Metab. 81:1996;2742-2745.
119. Anawalt B.D., Bebb R.A., Matsumoto A.M., Groome N.P., Illingworth P.J., McNeilly A.S., Bremner W.J. Serum inhibin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction. J Clin Endocrinol Metab. 81:1996;3341-3345.
120. Illingworth P.J., Groome N.P., Byrd W., Rainey W.E., McNeilly A.S., Mather J.P., Bremner W.J. Inhibin-B A likely candidate for the physiologically important form of inhibin in men . J Clin Endocrinol Metab. 81:1996;1321-1325.
121. Rivier C., Vale W. Immunoneutralization of endogenous inhibin modifies hormone secretion and ovulation rate in the rat. Endocrinology. 125:1989;152-157.
122. Molskness T.A., Woodruff T.K., Hess D.L., Dahl K.D., Stouffer R.L. Recombinant human inhibin-A administered early in the menstrual cycle alters concurrent pituitary and follicular, plus subsequent luteal, function in rhesus monkeys. J Clin Endocrinol Metab. 81:1996;4002-4006.
123. Stouffer R.L., Dahl K.D., Hess D.L., Woodruff T.K., Mather J.P., Molskness T.A. Systemic and intraluteal infusion of inhibin A or activin A in rhesus monkeys during the luteal phase of the menstrual cycle. Biol Reprod. 50:1994;888-895.
124. Woodruff T.K., Krummen L.A., Lyon R., Stocks D.L., Mather J.P. Recombinant human inhibin A and recombinant human activin A regulate pituitary and ovarian function in the adult female rat. Endocrinology. 132:1993;2332-2341.
125. Stouffer R.L., Woodruff T.K., Dahl K.D., Hess D.L., Mather J.P., Molskness T.A. Human recombinant activin-A alters pituitary luteinizing hormone and follicle-stimulating hormone secretion, follicular development, and steroidogenesis, during the menstrual cycle in rhesus monkeys. J Clin Endocrinol Metab. 77:1993;241-248.
126. Schwall R., Schmelzer C.H., Matsuyama E., Mason A.J. Multiple actions of recombinant activin-A in vivo. Endocrinology. 125:1989;1420-1423.
127. Rivier C., Vale W. Effect of recombinant activin-A on gonadotropin secretion in the female rat. Endocrinology. 129:1991;2463-2465.
128. McLachlan R.I., Dahl K.D., Bremner W., Schwall R., Schmelzer C.H., Mason A.J., Steiner R.A. Recombinant human activin-A stimulates basal FSH and GnRH-stimulated FSH and LH release in the adult male macaque, Macaca fascicularis. Endocrinology. 125:1989;2787-2789.
129. DePaolo L.V., Shimonaka M., Schwall R.H., Ling N. In vivo comparison of the follicle-stimulating hormone-suppressing activity of follistatin and inhibin in ovariectomized rats. Endocrinology. 128:1991;668-674.
130. Muttukrishna S., Fowler P.A., George L., Groome N.P., Knight P.G. Changes in peripheral serum levels of total activin A during the human menstrual cycle and pregnancy. J Clin Endocrinol Metab. 81:1996;3328-3334.
131. Corrigan A.Z., Bilezikjian L.M., Carroll R.S., Bald L.N., Schmelzer C.H., Fendly B.M., Mason A.J., Chin W.W., Schwall R.H., Vale W. Evidence for an autocrine role of activin B within rat anterior pituitary cultures. Endocrinology. 128:1991;1682-1684.
132. Harada K., Shintani Y., Sakamoto Y., Wakatsuki M., Shitsukawa K., Saito S. Serum immunoreactive activin A levels in normal subjects and patients with various diseases. J Clin Endocrinol Metab. 81:1996;2125-2130.
133. Petraglia F., Garg S., Florio P., Sadick M., Gallinelli A., Wong W-L, Krummen L., Comitini G., Mather J.P., Woodruff T.K. Activin A and activin B measured in maternal serum, cord blood serum and amniotic fluid during human pregnancy. Endocr J. 1:1993;323-327.
134. Illingworth P.J., Groome N.P., Duncan W.C., Grant V., Tovanabutra S., Baird D.T., McNeilly A.S. Measurement of circulating inhibin forms during the establishment of pregnancy. J Clin Endocrinol Metab. 81:1996;1471-1475.
135. Wallace E.M., Riley S.C., Crossley J.A., Ritoe S.C., Horne A., Shade M., Ellis P.M., Aitken D.A., Groome N.P. Dimeric inhibins in amniotic fluid, maternal serum, and fetal serum in human pregnancy. J Clin Endocrinol Metab. 82:1997;218-222.
136. Wallace E.M., Crossley J.A., Groome N.P., Aitken D.A. Amniotic fluid inhibin-A in chromosomally normal and Down's syndrome pregnancies. J Endocrinol. 152:1997;109-112.
137. Wallace E.M., Swanston I.A., McNeilly A.S., Ashby J.P., Blundell G., Calder A.A., Groome N.P. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A. Clin Endocrinol. 44:1996;17-21.
138. Petraglia F., De Vita D., Gallinelli A., Aguzzoli L., Genazzani A.R., Romero R., Woodruff T.K. Abnormal concentration of maternal serum activin-A in gestational diseases. J Clin Endocrinol Metab. 80:1995;558-561.
139. Petraglia F., Gallinelli A., De Vita D., Lewis K., Mathews L., Vale W. Activin at parturition Changes of maternal serum levels and evidence for binding sites in placenta and fetal membranes . Obstet Gynecol. 84:1994;278-282.
140. Hillier S.G., Yong E.L., Illingworth P.J., Baird D.T., Schwall R.H., Mason A.J. Effect of recombinant activin on androgen synthesis in cultured human thecal cells. J Clin Endocrinol Metab. 72:1991;1206-1211.
141. Hillier S.G., Yong E.L., Illingworth P.J., Baird D.T., Schwall R.H., Mason A.J. Effect of recombinant inhibin on androgen synthesis in cultured human thecal cells. Mol Cell Endocrinol. 75:1991;R1-R6.
142. Miro F., Hillier S.G. Relative effects of activin and inhibin on steroid hormone synthesis in primate granulosa cells. J Clin Endocrinol Metab. 75:1992;1556-1561.
143. Rabinovici J., Spencer S.J., Doldi N., Goldsmith P.C., Schwall R., Jaffe R.B. Activin-A as an intraovarian modulator Actions, localization, and regulation of the intact dimer in human ovarian cells . J Clin Invest. 89:1992;1528-1536.
144. Li W., Yuen B., Leung P.C.K. Inhibition of progestin accumulation by activin-A in human granulosa cells. J Clin Endocrinol Metab. 75:1992;285-289.
145. Hillier S.G., Miro F. Inhibin, activin, and follistatin Potential roles in ovarian physiology . Ann NY Acad Sci. 687:1993;29-38.
146. Findlay J.K. An update on the roles of inhibin, activin, and follistatin as local regulators of folliculogenesis. Biol Reprod. 48:1993;15-23.
147. Hillier S.G. Hormonal control of folliculogenesis and luteinization. Findlay J.K. Molecular Biology of the Female Reproductive System. 1994;1-35 Academic Press, New York.
148. Li R., Phillips D.M., Mather J.P. Activin promotes ovarian follicle development in vitro. Endocrinology. 136:1995;849-856.
149. Miro F., Hillier S.G. Modulation of granulosa cell deoxyribonucleic acid synthesis and differentiation by activin. Endocrinology. 137:1996;464-468.
150. Brannian J.D., Woodruff T.K., Mather J.P., Stouffer R.L. Activin-A inhibits progesterone production by macaque luteal cells in culture. J Clin Endocrinol Metab. 75:1992;756-761.
151. Roy S.K., Hughes J. Ontogeny of granulosa cells in the ovary Lineage-specific expression of transforming growth factor β2 and transforming growth factor β1 . Biol Reprod. 51:1994;821-830.
152. Hirobe S., He W.W., Gustafson M.L., MacLaughlin D.T., Donahoe P.K. Müllerian inhibiting substance gene expression in the cycling rat ovary correlates with recruited or Graafian follicle selection. Biol Reprod. 50:1994;1238-1243.
153. Jaatinen R., Rosen V., Tuuri T., Ritvos O. Identification of ovarian granulosa cells as a novel site of expression for bone morphogenetic protein-3 (BMP-3/osteogenin) and regulation of BMP-3 messenger ribonucleic acids by chorionic gonadotropin in cultured human granulosa-luteal cells. J Clin Endocrinol Metab. 81:1996;3877-3882.
154. McPherron A.C., Lee S-J. GDF-3 and GDF-9 Two new members of the transforming growth factor-β superfamily containing a novel pattern of cysteines . J Biol Chem. 268:1993;3444-3449.
155. Dong J., Albertini D.F., Nishimori K., Kumar T.R., Lu N., Matzuk M.M. Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature. 383:1996;531-535.